This grant funds research to advance understanding of STXBP1 biology and develop new therapies for STXBP1-related disorders.
Funder: Stxbp1 Foundation
Due Dates: Rolling (Letters of Intent accepted year-round)
Funding Amounts: Seed Grant: up to $25,000 (1 year) | Trainee Grant: up to $60,000/year (renewable) | Innovation Grant: up to $100,000/year (renewable) | Clinical Grant: up to $150,000 (1 year) | Direct costs only, no indirects
Summary: Supports investigator-led research advancing understanding and treatment of STXBP1 disorders, including biology, biomarkers, mechanisms, and therapies.
The STXBP1 Foundation's Grants Program funds investigator-led research projects aimed at deepening the understanding of STXBP1 biology and accelerating the development of transformative therapies for STXBP1-related disorders. Priority research areas include biomarker and clinical endpoint development, mechanisms of neurodegeneration, genotype-phenotype relationships, non-CNS functions of the STXBP1 protein, and drug repurposing opportunities. The program seeks to fill knowledge gaps, encourage innovative research, and ultimately improve outcomes for individuals affected by STXBP1 disorders.